InnoCare Pharma Eulerpool Новини

InnoCare Pharma Eulerpool News

InnoCare Pharma Новини за акции

InnoCare Pharma се наблюдава от множество журналисти и инвеститори по целия свят. Най-актуалните InnoCare Pharma новини събираме тук.

• 9 октомври ·

  Yahoo
  InnoCare Announces Phase II Study Results of TYK2 Inhibitor ICP-488 Meet Primary Endpoint in Psoriasis Patients
• 19 септември ·

  Yahoo
  InnoCare Announces Approval of Clinical Trial of BCL2 Inhibitor ICP-248 for Acute Myeloid Leukemia in China
• 13 септември ·

  Yahoo
  Latest Data of InnoCare’s Orelabrutinib Presented at the European Society for Medical Oncology (ESMO) Congress 2024
• 20 август ·

  Yahoo
  InnoCare Releases 2024 Interim Results and Business Highlights
• 31 юли ·

  Yahoo
  British Journal of Cancer: Zurletrectinib is a next-generation TRK inhibitor with strong intracranial activity against NTRK fusion-positive tumors with on-target resistance to first-generation agents
• 24 юли ·

  Yahoo
  InnoCare Announces First Subject Dosed in Clinical Trial of TYK2 Inhibitor ICP-332 in the U.S.
• 20 юни ·

  Yahoo
  InnoCare Announces the Acceptance of Biologics License Application for Tafasitamab in Combination with Lenalidomide for the treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma in Adult Patients in China
• 14 юни ·

  Yahoo
  Data of InnoCare’s Robust Pipelines Presented at the European Hematology Association (EHA) 2024 Hybrid Congress
• 11 юни ·

  Yahoo
  InnoCare Announces Clearance of Clinical Trial of TYK2 Inhibitor ICP-332 by U.S. FDA
• 20 май ·

  SeekingAlpha
  Week In Review: Takeda Options Alzheimer's Therapy From AC Immune In $2.2 Billion Deal